US2012178674A1PendingUtilityA1
Mixture of non-digestible oligosaccharides for stimulating the immune system
Est. expiryJul 15, 2029(~3 yrs left)· nominal 20-yr term from priority
A61P 37/08A61P 37/04A61P 37/06A61P 31/00A61P 3/02A61P 11/02A61P 11/06A61P 17/00C12N 2760/16134A61K 39/12C12N 2760/16211C12N 2760/16234C12N 2760/16111A61K 2039/55A61K 39/145A61K 2039/5252A61K 2039/57A61K 31/702A23L 33/40A23V 2002/00A23L 33/10A61K 39/39A61K 2039/55511
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
Claims
exact text as granted — not AI-modified1 . A nutritional composition, comprising fucosyllactose and betagalacto-oligosaccharides, wherein the composition is not human milk.
2 . The nutritional composition according to claim 1 , further comprising fructo-oligosaccharides and/or uronic acid oligosaccharides.
3 . The nutritional composition according to claim 1 , further comprising fructo-oligosaccharides and uronic acid oligosaccharides.
4 . The nutritional composition according to claim 1 , wherein the fucosyllactose comprises 2′-fucosyllactose.
5 . The nutritional composition according to claim 1 , wherein the betagalacto-oligosaccharides have over 80% beta 1,4 and beta 1,6 linkages.
6 . The nutritional composition according to claim 1 , comprising protein, digestible carbohydrates and fat, wherein protein provides 5 to 50%, digestible carbohydrates provide 15 to 85%, and fat provides 5 to 50% of calories based on total calories.
7 . The nutritional composition according to claim 1 , comprising 0.07 to 1 wt. % of the 2′-fucosyllactose based on dry weight of the composition.
8 . The nutritional composition according to claim 1 , wherein the composition is an infant formula.
9 . A method of providing nutrition comprising administering to a mammal in need thereof a composition according to claim 1 .
10 . The method according to claim 9 , wherein the mammal is a human infant, an elderly person, an oncology patient and/or a HIV patient.
11 . A method of stimulating the immune system, comprising administering to a mammal in need thereof a composition according to claim 1 .
12 . A method of enhancement of a vaccination response in a mammal, comprising administering to the mammal a composition according to claim 1 .
13 . A method of treatment and/or prevention of infections and/or disease, comprising administering to a mammal in need thereof a composition according to claim 1 .
14 . A method of treatment and/or prevention of an immune disorder selected from the group consisting of asthma, allergy, atopic dermatitis, allergic conjunctivitis, dust mite allergy, urticaria and allergic rhinitis, comprising administering to a mammal in need thereof a composition according to claim 1 .
15 . The nutritional composition according to claim 2 , comprising 0.25 wt % to 15 wt % of the sum of betagalacto-oligosaccharides, fructo-oligosaccharides and uronic acid oligosaccharides, based on dry weight of the composition.
16 . The method according to claim 11 , wherein the immune system stimulation comprises increasing Th1 response and/or increasing Th1/Th2 balance.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.